Should you buy PANG stock?
Last updated:
Based on market data through , StockInvest.us rates Pangaea Oncology SA (PANG) as a Strong Buy Candidate with a technical score of 6.45 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation.
- Buy signal since
- Price since signal Up 37.76%
- 3-month trend forecast Up 82.79%
- +252.5% price growth over the last year
- +272.4% YTD performance
- Consistently positive technical signals over the last month
High volatility in Pangaea Oncology SA stock price on Monday which ended trading at $38.91
(Market data through Aug 10, 2026)
The Pangaea Oncology SA stock price gained 11.56% on the last trading day (Monday, 10th Aug 2026), rising from $34.88 to $38.91. During the last trading day the stock fluctuated 11.56% from a day low at $34.88 to a day high of $38.91. The price has risen in 7 of the last 10 days and is up by 45.18% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 28 thousand more shares were traded than the day before. In total, 48 thousand shares were bought and sold for approximately $1.85 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 82.79% during the next 3 months and, with a 90% probability hold a price between $52.53 and $78.22 at the end of this 3-month period.
PANG Signals & Forecast
Mostly positive signals in the chart today. The Pangaea Oncology SA stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.20 and $30.41. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 48.31%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Pangaea Oncology SA stock
On the downside, the stock finds support just below today's level from accumulated volume at $33.99 and $31.90. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pangaea Oncology SA finds support just below today's level at $33.99. If this is broken, then the next support from accumulated volume will be at $31.90 and $30.31.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $4.03 between high and low, or 11.56%. For the last week, the stock has had daily average volatility of 8.00%.
Our recommended stop-loss: $37.50 (-3.64%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 8 days ago.)
Trading Expectations (PANG) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Pangaea Oncology SA to open at $37.57, and during the day (based on 14 day Average True Range), to move between $37.64 and $40.19, which gives a possible trading interval of +/-$2.55 (+/-6.76%) up or down from last closing price. If Pangaea Oncology SA takes out the full calculated possible swing range there will be an estimated 6.76% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $33.99, some $4.92 (12.65%) from the current price of $38.91, our system finds the risk reward attractive.
Is Pangaea Oncology SA stock A Buy?
Pangaea Oncology SA holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
6.450
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $37.57 ( 3.45%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PANG Performance
Trading levels for PANG
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 41.60 | 6.91% |
| R2 | 40.06 | 2.95% |
| R1 | 39.11 | 0.504% |
| Price | 38.91 | |
| S1 | 36.03 | -7.41% |
| S2 | 35.08 | -9.86% |
| S3 | 33.54 | -13.82% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 38.91 | |
| S1 | 33.99 | -12.65% |
| S2 | 31.90 | -18.01% |
| S3 | 30.31 | -22.10% |
PANG Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 30, 2025 | Dec 30, 2025 | Jan 02, 2026 | $1.30 | 11.40% |
FAQ
Click here for our free guide on how to buy Pangaea Oncology SA Stock.
Buy PANG